Evidence map›Paper›PMID 42541240›Full record

ArticleBiotechnology reports (Amsterdam, Netherlands)2026

Biochemical and functional benchmarking of plant protein hydrolysates in serum-reduced adherent CHO-K1 cell culture.

F Compeau, G Yalkin, P Mortamais, D Lutomski

Abstract read
In one paragraph

Article in Biotechnology reports (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

F CompeauUniversité Sorbonne Paris Nord, Unité de Recherche en Ingénierie Tissulaire (URIT), F-93000, Bobigny, France.
G YalkinOrganotechnie, La Courneuve, Paris, France.
P MortamaisOrganotechnie, La Courneuve, Paris, France.
D LutomskiUniversité Sorbonne Paris Nord, Unité de Recherche en Ingénierie Tissulaire (URIT), F-93000, Bobigny, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese Hamster Ovary (CHO) cells are used for therapeutic protein production. Although industrial platforms rely on serum-free media, fetal bovine serum (FBS) remains common in research and development. Reducing serum while maintaining cell growth is of interest. In this study, CHO-K1 cells were adapted from 10% to 1% FBS in Ham's F-12 medium. Six plant protein hydrolysates (wheat, soy, pea, broad bean, rice, and a rice-pea blend) were biochemically characterized and evaluated for their effects on cell proliferation under serum-reduced conditions. CHO-K1 cells tolerated adaptation to 1% FBS, although proliferation decreased compared to 10% FBS. Supplementation with hydrolysates improved cell growth in a concentration-dependent but nonlinear manner, with low concentrations more favorable than higher concentrations. Wheat (W106) and broad bean (F120) peptones showed the strongest effects, partially restoring proliferation toward high-serum conditions. This study provides an evaluation of plant hydrolysates and supports their use as supplements in serum-reduced CHO-K1 culture.

Indexed as

Cell proliferationCho-k1 cellsPeptonesPlant protein hydrolysatesSerum-reduced culture

Identifiers

PMID42541240
PMCPMC13427452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.